ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin

October 1, 1976

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984

AMA Anti-Tobacco, Stop-Smoking Program Uses TV Marketing

April 15, 1994

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011